{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T03:52:39Z","timestamp":1777953159402,"version":"3.51.4"},"reference-count":87,"publisher":"Informa UK Limited","issue":"9","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine"],"published-print":{"date-parts":[[2026,5,3]]},"DOI":"10.1080\/17435889.2026.2648661","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T04:56:42Z","timestamp":1774241802000},"page":"1385-1394","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Nanocarriers for potential treatment of sensorineural hearing loss and retinitis in congenital cytomegalovirus"],"prefix":"10.1080","volume":"21","author":[{"given":"Mary","family":"Daniel","sequence":"first","affiliation":[{"name":"University of British Columbia","place":["Vancouver, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Horacio","family":"Bach","sequence":"additional","affiliation":[{"name":"University of British Columbia","place":["Vancouver, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2026,3,22]]},"reference":[{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2023.1276912"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.655"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0252309"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.3390\/v16010012"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.535"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.3390\/v15061385"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-4453(17)30197-4"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1093\/pch\/pxx002"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.5812\/ijp.118874"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijporl.2024.112070"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.20736"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1009169"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit609"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.3390\/v16081342"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2005.09.016"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ddmec.2006.02.009"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11185335"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aao0935"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-8749.2002.tb00298.x"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.3928\/01913913-20090706-16"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.3390\/v16071110"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40123-020-00257-7"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.86.2.248"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2018.08.015"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(03)00192-6"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.3390\/clinpract14060191"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.3345\/cep.2022.01032"},{"key":"e_1_3_5_30_1","first-page":"27","volume-title":"Infect Dis Pharmacol","author":"Weimer KED","year":"2019","unstructured":"Weimer KED, Permar SR. Chapter 3 - when and how to treat neonatal CMV infection. In: Benitz WE, Smith PB, editors. Infect Dis Pharmacol. Philadelphia: Elsevier; 2019. p. 27\u201336."},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1404599"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S30725"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1080\/21691401.2019.1573182"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2021.809443"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2018.04.028"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.1109\/TMAG.2012.2221456"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.1038\/jp.2012.139"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.202403142"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.4103\/ijo.IJO_2338_20"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cclet.2017.07.022"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nxnano.2024.100129"},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2023.123427"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.1080\/17425247.2017.1360863"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15061648"},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.2217\/nnm.12.5"},{"key":"e_1_3_5_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2018.06.011"},{"key":"e_1_3_5_47_1","doi-asserted-by":"publisher","DOI":"10.1109\/MCS.2012.2189052"},{"key":"e_1_3_5_48_1","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2017.00268"},{"key":"e_1_3_5_49_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-bioeng-071813-105206"},{"key":"e_1_3_5_50_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.HJ.0000521759.00742.6b"},{"issue":"20","key":"e_1_3_5_51_1","first-page":"4686","article-title":"Clinical experiences with magnetic drug targeting: a phase I study with 4\u2032-epidoxorubicin in 14 patients with advanced solid tumors","volume":"56","author":"L\u00fcbbe AS","year":"1996","unstructured":"L\u00fcbbe AS, Bergemann C, Riess H, et al. Clinical experiences with magnetic drug targeting: a phase I study with 4\u2032-epidoxorubicin in 14 patients with advanced solid tumors. Cancer Res. 1996;56(20):4686\u20134693.","journal-title":"Cancer Res"},{"key":"e_1_3_5_52_1","doi-asserted-by":"publisher","DOI":"10.3390\/ma12040617"},{"key":"e_1_3_5_53_1","doi-asserted-by":"publisher","DOI":"10.1159\/000090685"},{"key":"e_1_3_5_54_1","doi-asserted-by":"publisher","DOI":"10.1097\/MAO.0000000000000445"},{"key":"e_1_3_5_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2022.104086"},{"key":"e_1_3_5_56_1","doi-asserted-by":"publisher","DOI":"10.1039\/D2FO02382B"},{"key":"e_1_3_5_57_1","doi-asserted-by":"publisher","DOI":"10.1097\/MLG.0b013e31815f8e41"},{"key":"e_1_3_5_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2020.120038"},{"key":"e_1_3_5_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2012.09.010"},{"key":"e_1_3_5_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2022.105362"},{"key":"e_1_3_5_61_1","doi-asserted-by":"publisher","DOI":"10.1002\/lary.30975"},{"key":"e_1_3_5_62_1","doi-asserted-by":"publisher","DOI":"10.3109\/21691401.2014.926456"},{"key":"e_1_3_5_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2012.10.018"},{"key":"e_1_3_5_64_1","doi-asserted-by":"publisher","DOI":"10.1039\/D0RA04971A"},{"key":"e_1_3_5_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2025.113992"},{"key":"e_1_3_5_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2020.119084"},{"key":"e_1_3_5_67_1","doi-asserted-by":"publisher","DOI":"10.1080\/10611860290022660"},{"key":"e_1_3_5_68_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00161017"},{"key":"e_1_3_5_69_1","doi-asserted-by":"publisher","DOI":"10.1080\/10837450.2023.2216784"},{"key":"e_1_3_5_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0928-0987(00)00169-X"},{"key":"e_1_3_5_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(98)98020-4"},{"key":"e_1_3_5_72_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.78.9.677"},{"key":"e_1_3_5_73_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.1c00046"},{"key":"e_1_3_5_74_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.25474"},{"key":"e_1_3_5_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2018.03.034"},{"key":"e_1_3_5_76_1","doi-asserted-by":"publisher","DOI":"10.1080\/10717544.2017.1413448"},{"key":"e_1_3_5_77_1","doi-asserted-by":"publisher","DOI":"10.3109\/1061186X.2015.1052073"},{"key":"e_1_3_5_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2017.07.002"},{"key":"e_1_3_5_79_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13247651"},{"key":"e_1_3_5_80_1","volume-title":"Ethical conduct of clinical research involving children","author":"Institute of Medicine (US) Committee on Clinical Research Involving Children","year":"2004","unstructured":"Institute of Medicine (US) Committee on Clinical Research Involving Children. Ethical conduct of clinical research involving children. Field MJ, Behrman RE, editors. Washington (DC): National Academies Press (US); 2004. PMID: 20669469."},{"key":"e_1_3_5_81_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcl.2012.07.007"},{"key":"e_1_3_5_82_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines13050435"},{"key":"e_1_3_5_83_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41578-021-00358-0"},{"key":"e_1_3_5_84_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiae114"},{"key":"e_1_3_5_85_1","unstructured":"A study to evaluate the efficacy safety and immunogenicity of mRNA-1647 cytomegalovirus (CMV) vaccine in healthy participants 16 to 40 years of age. 2025 [cited 2025 Dec 1]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05085366"},{"key":"e_1_3_5_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2024.113945"},{"key":"e_1_3_5_87_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13346-020-00740-5"},{"key":"e_1_3_5_88_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13346-021-01024-2"},{"key":"e_1_3_5_89_1","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.2858"}],"container-title":["Nanomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17435889.2026.2648661","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T14:21:15Z","timestamp":1777904475000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17435889.2026.2648661"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,22]]},"references-count":87,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,5,3]]}},"alternative-id":["10.1080\/17435889.2026.2648661"],"URL":"https:\/\/doi.org\/10.1080\/17435889.2026.2648661","relation":{},"ISSN":["1743-5889","1748-6963"],"issn-type":[{"value":"1743-5889","type":"print"},{"value":"1748-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,22]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=innm20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=innm20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-10-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-22","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}